Proposed pathophysiology of extracellular matrix remodeling during biliary fibrosis progression and reversal. Cholestasis (BDL) triggers cholangiocyte activation and proliferation (1), which upregulate profibrogenic αvβ6 integrin and soluble factors, e.g., TGF-β, PAI-1 and connective tissue growth factor, leading to paracrine myofibroblast activation (2) and enhanced collagen synthesis. Aberrant ductular proliferation (3) further amplifies HSC/MF recruitment and fibrous matrix deposition, leading to fibrosis and loss of normal liver architecture. Upon restoration of bile flow by RY-anastomosis (RY), activated cholangiocytes undergo rapid deactivation (4) and apoptosis (5), which removes the profibrogenic stimuli acting on myofibroblasts. Cholangiocyte apoptosis triggers recruitment of CD68+ macrophages into scarred portal tracts to remove apoptotic cholangiocytes via phagocytosis (6) and to upregulate MMP-3, -8, and-9 to remodel the scar, leading to dissolution of fibrous septa and restoration of normal liver architecture. a, activated; b, proliferating cholangiocyte; c, apoptotic cholangiocyte; d, myofibroblast; e, macrophage; f, fibrotic matrix.